Early postoperative enteral nutrition and its impact on postoperative recovery in gastrointestinal tumor surgery. [PDF]
Weng PH, Du Y, Yuan F.
europepmc +1 more source
Room G, 10/16/2000 2: 00 PM - 4: 00 PM (PS) Enteral Nutrition Increases Mesenteric Blood Flow in Rats during Vasopressin Administration [PDF]
Pamela R. Roberts +4 more
openalex +1 more source
ASPEN Safe Practices for Enteral Nutrition Therapy [Formula: see text].
J. Boullata +18 more
semanticscholar +1 more source
Probiotic‐Based Materials as Living Therapeutics
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio +2 more
wiley +1 more source
Intermittent enteral nutrition may increase gastrointestinal complications and mortality in critically ill patients. [PDF]
Hu P, Wu H, Zhang K, Li A, Chen Q.
europepmc +1 more source
Significance of Home Enteral Nutritional Support in Patients after Surgery for Esophageal Cancer.
Michihiko Kitamura +5 more
openalex +2 more sources
Biological and biologically‐inspired functional nanostructures with structural, thermal, optical, and sensing applications are reviewed. The role of nanoscale features in biological materials on performance is described, and their blueprints are used for bio‐inspired nanomaterials, synthesized using advanced techniques (i.e., photolithography, bio ...
Chao Hsuan (Joseph) Sung +15 more
wiley +1 more source
Clinical efficacy of ERAS plus enteral nutrition in patients undergoing laparoscopic surgery for gynecologic malignancies. [PDF]
Xia H +6 more
europepmc +1 more source
Enteral and parenteral nutrition: evidence-based approach [PDF]
Khursheed N. Jeejeebhoy
openalex +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source

